AlphaCrest Capital Management LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
AlphaCrest Capital Management LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2022$658,000
+224.1%
8,883
+176.8%
0.04%
+263.6%
Q1 2022$203,000
-68.5%
3,209
-73.6%
0.01%
-54.2%
Q4 2021$645,000
+184.1%
12,166
+256.8%
0.02%
+140.0%
Q2 2021$227,000
-63.0%
3,410
-38.4%
0.01%
-70.6%
Q1 2021$614,000
+24.3%
5,533
+33.1%
0.03%
-17.1%
Q4 2020$494,000
+65.2%
4,156
+24.5%
0.04%
-18.0%
Q2 2020$299,000
+9.5%
3,339
+22.1%
0.05%
+51.5%
Q1 2020$273,000
-33.7%
2,735
-23.8%
0.03%
-2.9%
Q4 2019$412,000
+5.1%
3,589
+15.6%
0.03%
+41.7%
Q3 2019$392,000
-13.5%
3,105
-40.1%
0.02%
-65.2%
Q1 2019$453,0005,1820.07%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders